MODELING THE IMPACT OF THE VACCINE CANDIDATE TAK-003 ON THE INCIDENCE OF DENGUE IN FRENCH OVERSEAS TERRITORIES

被引：0
|
作者：
Nucit, A. [1 ]
Moreau, R. [2 ]
Massetti, M. [2 ]
Strub, C. [3 ]
Kharitonova, E. [4 ]
Tytula, A. [5 ]
Zawieja, J. [5 ]
Leleu, H. [2 ]
Shen, J. [6 ]
机构：
[1] Takeda France SAS, F-75 Paris, France
[2] Publ Hlth Expertise, F-75 Paris, France
[3] Takeda France SAS, Paris, France
[4] Putnam PHMR, Paris, France
[5] Putnam PHMR, Krakow, Poland
[6] Takeda Pharmaceut Int AG, Zurich, Switzerland
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH47
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 46 条
  • [21] Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination
    Sirivichayakul, Chukiat
    Biswal, Shibadas
    Saez-Llorens, Xavier
    Lopez-Medina, Eduardo
    Borja-Tabora, Charissa
    Bravo, Lulu
    Kosalaraksa, Pope
    Alera, Maria Theresa
    Reynales, Humberto
    Rivera, Luis
    Watanaveeradej, Veerachai
    Yu, Delia
    Espinoza, Felix
    Dietze, Reynaldo
    Fernando, Lakkumar
    Wickramasinghe, V. Pujitha
    Moreira Jr, Edson Duarte
    Fernando, Asvini D.
    Gunasekera, Dulanie
    Luz, Kleber
    Venancio da Cunha, Rivaldo
    Oliveira, Ana Lucia
    Rauscher, Martina
    Fan, Huihao
    Borkowski, Astrid
    Escudero, Ian
    Tuboi, Suely
    Lloyd, Eric
    Tricou, Vianney
    Folschweiller, Nicolas
    Lefevre, Inge
    Vargas, Luis Martinez
    Wallace, Derek
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (06): : e1214 - e1225
  • [22] Early onset of protection of the TAK-003 dengue vaccine: Data from the DEN-301 clinical trial
    Petri, Eckhardt
    Biswal, Shibadas
    Lloyd, Eric
    Tricou, Vianney
    Folschweiller, Nicolas
    VACCINE, 2024, 42 (26)
  • [23] PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE (TAK-003) IN A LARGE CATCH-UP COHORT IN PUERTO RICO
    Shen, J.
    Zerda, I
    Hanley, R.
    Kharitonova, E.
    Janusz, Z.
    Biswal, S.
    Sharma, M.
    Tricou, V
    Kastner, R.
    Wallace, D.
    Rosas, A.
    VALUE IN HEALTH, 2024, 27 (06) : S66 - S66
  • [24] Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
    White, Laura J.
    Young, Ellen F.
    Stoops, Mark J.
    Henein, Sandra R.
    Adams, Elizabeth C.
    Baric, Ralph S.
    de Silva, Aravinda M.
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (03):
  • [25] TAK-003 VACCINE-DRIVEN NEUTRALIZATION OF DIVERSE DENGUE GENOTYPES CIRCULATING IN ASIA PACIFIC AND LATIN AMERICA REGIONS
    Karwal, Lovkesh
    Kaiser, Maima
    Bohning, Kelly
    Zahralban-Steele, Melissa
    Nascimento, Eduardo J.
    DeMaso, Christina
    Baldwin, Whitney
    Fernandez, Stefan
    Sharma, Mayuri
    Dean, Hansi
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 51 - 51
  • [26] A Methodological Approach to Measuring the Impact of TAK-003 for the Prevention of Dengue in Dourados, Brazil: Optimizing Strategies for Public Health
    Ghezzi, Benedetta
    Valencia, Cristina
    de Oliveira, Roberto Dias
    Tsuha, Daniel
    Lucena Junior, Waldno
    Di Pasquale, Alberta
    Mc Namara, Morgan
    Senra, Juliana
    Abud, Denise
    Croda, Julio
    VACCINES, 2025, 13 (02)
  • [27] TAK003 dengue vaccine: A promising tool for dengue control
    Nitika, Nitika
    Bharti, Praveen K.
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2024, 17 (11) : 477 - 478
  • [28] EFFICACY AND SAFETY OF TAKEDA'S TETRAVALENT DENGUE VACCINE CANDIDATE (TAK-003) AFTER 4.5 YEARS OF FOLLOW-UP: RESULTS FROM PARTICIPANTS IN ASIA
    Green, A.
    Biswal, S.
    Lloyd, E.
    Tricou, V.
    Folschweiller, N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S11 - S11
  • [29] Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study
    Tricou, Vianney
    Essink, Brandon
    Ervin, John E.
    Turner, Mark
    Escudero, Ian
    Rauscher, Martina
    Brose, Manja
    Lefevre, Inge
    Borkowski, Astrid
    Wallace, Derek
    PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (03):
  • [30] DISEASE IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE TAK003 IN THAILAND
    Shen, J.
    Kharitonova, E.
    Biswal, S.
    Sharma, M.
    Aballea, S.
    Tytula, A.
    Zawieja, J.
    Towle, P.
    Hanley, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S141 - S141
12345